1.
Lin N, Sun X, Zhou H, Zou L, Zhou K, Liu L, Yang H, Hu K, Cai Q, Liu Y, Jin J, Zhang L, Li W, Guo Y, Yang W, Luo F, Wang Z, Zhu R, Yang L, Song D, Song Y, Zhu J. Loncastuximab tesirine in Chinese patients with relapsed or refractory diffuse large B-cell lymphoma: a multicenter, open-label, single-arm, phase II trial. Haematologica 2025;110(3):683-692; https://doi.org/10.3324/haematol.2024.284973.